MK-0000-111

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0000-111, covering 2012-04-19 to 2012-04-19. Get the full timeline:

Most recent: Clinical Trial Update: Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED) [Phase 2]